Impact of valve size, predicted effective and indexed effective orifice area after aortic valve replacement.

aortic valve replacement effective orifice area indexed effective orifice area patient prosthesis mismatch patient prosthesis mismatchpatient prosthesis mismatchpatient prosthesis mismatch

Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 10 08 2020
revised: 30 11 2020
accepted: 06 12 2020
pubmed: 12 1 2021
medline: 15 5 2021
entrez: 11 1 2021
Statut: ppublish

Résumé

The impact of manufacturer labeled prosthesis size and predicted effective orifice area (EOA) on long-term survival after aortic valve replacement is not clear although indexed effective orifice area (iEOA) has been associated with worse survival. Data was retrospectively collected from Jan 2000-Dec 2019 for prosthesis type, model, and size for isolated aortic valve replacements. Stratified survival was compared between groups and subgroups for labeled valve size, EOA and predicted patient prosthesis mismatch (PPM). A total of 3444 patients were included. Moderate and severe PPM was 15.6% and 1.6%, respectively. Cumulative lifetime hazard was worse for biological valves (mortality: biological 77.7% vs. mechanical 64.8%, p = .001). Moderate prosthetic aortic stenosis (AS), (EOA = 1-1.5 cm Predicted prosthetic moderate to severe AS and moderate to severe PPM adversely affect long term survival. Smaller valves are associated with reduced survival.

Identifiants

pubmed: 33428257
doi: 10.1111/jocs.15311
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

961-968

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Rahimtoola SH. The problem of valve prosthesis-patient mismatch. Circulation. 1978;58:20-24.
Pibarot P, Dumesnil JG. Valve prosthesis-patient mismatch, 1978 to 2011: from original concept to compelling evidence. J Am Coll Cardiol. 2012;60:1136-1139.
Daneshvar SA, Rahimtoola SH. Valve prosthesis-patient mismatch (VP-PM): a long term perspective. J Am Coll Cardiol. 2012;60(13):1123-1135.
Brewer RJ, Deck JD, Capati B, Nolan SP. The dynamic aortic root. Its role in aortic valve function. J Thorac Cardiovasc Surg. 1976;72(3):413-417.
Chambers JB, Oo L, Narracott A, Lawford PM, Blauth CI. Manufacturer's labelled size in six bileaflet mechanical aortic valves: a comparison of orifice size and bio-logical equivalence. J Thorac Cardiovasc Surg. 2003;125:1388-1393.
Garcia D, Pibarot P, Landry C, et al. Estimation of aortic valve effective orifice area by Doppler echocardiography: effects of valve inflow shape and flow rate. J Am Soc Echocardiogr. 2004;17:756-765.
Christakis GT, Buth KJ, Goldman BS, et al. Inaccurate and misleading valve sizing: a proposed standard for valve size nomenclature. Ann Thorac Surg. 1998;66:1198-1203.
Roques F, Michel P, Goldstone AR, Nashef SAM. The Logistic EuroSCORE. Eur Heart J. 2003;9:882-883.
Pibarot P, Dumesnil JG. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart. 2006;92(8):1022-1029.
Del Rizzo DF, Abdoh A, Cartier P, Doty D, Westaby S. Factors affecting left ventricular mass regression after aortic valve replacement with stentless valves. Semin Thorac Cardiovasc Surg. 1999;11(4 Suppl 1):114-120.
Florath I, Albert A, Rosendahl U, Ennker IC, Ennker J. Impact of valve prosthesis patient mismatch estimated by echocardiographic-determined effective orifice area on long-term outcome after aortic valve replacement. Am Heart J. 2008 Jun;155(6):1135-1142.
Fallon JM, DeSimone JP, Brennan JM, et al. The incidence and consequence of prosthesis-patient mismatch after surgical aortic valve replacement. Ann Thorac Surg. 2018;106(1):14-22.
Head SJ, Mokhles MM, Osnabrugge RL, et al. The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J. 2012;33(12):1518-1529.
Tully PJ, Aty W, Rice GD, Bennetts JS, Knight JL, Baker RA. Aortic valve prosthesis-patient mismatch and long-term outcomes: 19-year single-center experience. Ann Thorac Surg. 2013;96(3):844-850.
Das DeS, Nanjappa A, Morcos K, et al. The effect of patient-prosthesis mismatch on survival after aortic and mitral valve replacement: a 10 year, single institution experience. J Cardiothorac Surg. 2019;14(1):214.
LaPar DJ, Ailawadi G, Bhamidipati CM, et al. Small prosthesis size in aortic valve replacement does not affect mortality. Ann Thorac Surg. 2011;92(3):880-888.discussion 888.
Dayan V, Vignolo G, Soca G, Paganini JJ, Brusich D, Pibarot P. Predictors and outcomes of prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging. 2016;9(8):924-933.
Bleiziffer S, Eichinger WB, Hettich I, et al. Prediction of valve prosthesis-patient mismatch prior to aortic valve re-placement: which is the best method? Heart. 2007;93:615-620.
Cohen RG, Bourne ET. Industry-generated charts for the selection of stented aortic valve prostheses: clinical tool or marketing ploy? Ann Thorac Surg. 2011;91:1001-1002.
House CM, Nelson WB, Raikar GV, Ahmed I, Dahiya R. How reliable is an effective orifice area indexed chart? J HeartValve Dis. 2009;18:530-534.
George I, Guglielmetti LC, Bettinger N, et al. Aortic Valve annular sizing: intraoperative assessment versus preoperative multidetector computed tomography. Circ Cardiovasc Imaging. 2017;10(5):e005968.
Medalion B, Blackstone EH, Lytle BW, White J, Arnold JH, Cosgrove DM. Aortic valve replacement: is valve size important? J Thorac Cardiovasc Surg. 2000;119(5):963-974.
Liao Yan-biao, Li Yi-jian, Jun-li Li, et al. Incidence, predictors and outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement: a systematic review and meta-analysis. Sci Rep. 2017;7:15014.
Kulik A, Burwash IG, Kapila V, Mesana TG, Ruel M. Long-term outcomes after valve replacement for low-gradient aortic stenosis: impact of prosthesis-patient mismatch. Circulation. 2006;114(1 Suppl):I553-I558.
van Gils L, Clavel MA, Vollema EM, et al. Prognostic implications of moderate aortic stenosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2017;69:2383-2392.
Delesalle G, Bohbot Y, Rusinaru D, Delpierre Q, Maréchaux S, Tribouilloy C. Characteristics and prognosis of patients with moderate aortic stenosis and preserved left ventricular ejection fraction. J Am Heart Assoc. 2019;8:e011036.
Strange G, Stewart S, Celermajer D, et al. National echocardiography database of Australia contributing sites. Poor long-term survival in patients with moderate aortic stenosis. J Am Coll Cardiol. 2019;74(15):1851-1863.
Bertrand PB, Pettinari M, De Cannière H, et al. Effective orifice area during exercise in bileaflet mechanical valve prostheses. J Am Soc Echocardiogr. 2017;30(4):404-413.
Flameng W, Herregods MC, Vercalsteren M, Herijgers P, Bogaerts K, Meuris B. Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves. Circulation. 2010;121:2123-2129.

Auteurs

Suvitesh Luthra (S)

Institution - Wessex Cardiothoracic Centre, Division of Cardiac Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, UK.

Pietro G Malvindi (PG)

Institution - Wessex Cardiothoracic Centre, Division of Cardiac Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, UK.

Carlo Olevano (C)

Institution - Wessex Cardiothoracic Centre, Division of Cardiac Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, UK.

Anna Zingale (A)

Institution - Wessex Cardiothoracic Centre, Division of Cardiac Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, UK.

Hamdi Salem (H)

Institution - Wessex Cardiothoracic Centre, Division of Cardiac Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, UK.

Sunil K Ohri (SK)

Institution - Wessex Cardiothoracic Centre, Division of Cardiac Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH